Use of Pharmacogenetics in Bioequivalence Studies to Reduce Sample Size: An Example With Mirtazapine and CYP2D6

Pharmacogenomics Journal - United Kingdom
doi 10.1038/tpj.2012.29
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search